Has human pharmacokinetics been assessed after ocular administration of Cystadrops (mercaptamine hydrochloride)?

Human pharmacokinetics has not been assessed after ocular administration of Cystadrops (mercaptamine hydrochloride); systemic absorption is likely, but the recommended daily ocular dose is no more than approximately 0.4% of the highest recommended daily oral cysteamine dose in any age group.